BioCryst Pharmaceuticals, Inc. (BCRX)

BioCryst Pharmaceuticals Revenue

BioCryst Pharmaceuticals had revenue of $163.35M in the quarter ending June 30, 2025, with 49.41% growth. This brings the company's revenue in the last twelve months to $557.51M, up 45.85% year-over-year. In the year 2024, BioCryst Pharmaceuticals had annual revenue of $450.71M with 36.00% growth.

• Revenue (ttm): $557.51M
• Revenue Growth: +45.85%
• P/S Ratio: 3.12
• Revenue / Employee: $961,217
• Employees: 580
• Market Cap: 1.75B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	450.71M	119.30M	36.00%
Dec 31, 2023	331.41M	60.59M	22.37%
Dec 31, 2022	270.83M	113.66M	72.31%
Dec 31, 2021	157.17M	139.36M	782.38%
Dec 31, 2020	17.81M	-31.02M	-63.53%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.